Moderna
MRNA
#1630
Rank
โ‚ฌ8.85 B
Marketcap
22,91ย โ‚ฌ
Share price
-2.41%
Change (1 day)
-75.73%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -โ‚ฌ3.37 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚ฌ3.19 Billion. , an increase over its 2023 earnings that were of -โ‚ฌ3.57 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ3.27 Billion-8.22%
2023 -โ‚ฌ3.57 Billion-140.65%
2022 โ‚ฌ8.76 B-27.81%
2021 โ‚ฌ12.13 B-1911.15%
2020 -โ‚ฌ0.68 Billion44.7%
2019 -โ‚ฌ0.47 Billion28.63%
2018 -โ‚ฌ0.36 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ42.15 Million-98.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ19.34 B-691.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ38.1 Million-98.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.22 Billion-93.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ12.44 B-480.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-โ‚ฌ0.55 Billion-83.25%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ15.91 B-586.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.11 Billion-96.72%๐Ÿ‡บ๐Ÿ‡ธ USA